Orano Med
Alexandra Troubat has extensive experience in the logistics and supply chain sector, currently serving in multiple roles at Orano Med since January 2014, including Logistics Supply Chain and Office Manager. Prior to this, Alexandra worked as an Assistante at AREVA from 2007 to 2013 and held a position in accueil-vente at SNCF from 2000 to 2006. Alexandra's education includes ongoing training from IATA and IMDG as well as various degrees in office management and assistance from institutions such as CCI Limoges and the Rectorat Limoges. Notably, Alexandra holds a Licence in Office Management with high honors, a BTS in Assistant Direction, and a Bac PRO in Assistance-Conseil-Service.
This person is not in the org chart
This person is not in any offices
Orano Med
1 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.